E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/26/2008 in the Prospect News Investment Grade Daily.

S&P: Humana unchanged

Standard & Poor's said that Humana Inc.'s (BBB/stable) announcement that it has signed a definitive agreement to purchase the Medicare Advantage individual HMO business of UnitedHealth Group Inc. (A-/stable/A-2) will have no effect on the Humana ratings.

The agency noted that the Department of Justice has approved the transaction, but it is still subject to regulatory approvals from the Center for Medicare and Medicaid Services and the Nevada Division of Insurance.

According to S&P, the transaction price is about $185 million in cash, which Humana will likely finance through a combination of cash and debt.

The agency said that it expects that the transaction will have no material impact on Humana's 2008 earnings, debt leverage, or interest coverage.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.